At the time of clinical onset, the diabetes rats in the saline, His42, and delayed diabetes groups exhibited substantial loss of beta cells (Figures 2B, C, F, G, I) with the remaining insulin+ cells accounting for 7 ± 8% of the islet cells. This evidence concerns the gene INS and diabetes mellitus.